Treace Medical Concepts, Inc.
A medical technology company that makes instruments and implants for foot and ankle surgery, best known for the Lapiplasty procedure that corrects bunions in all three dimensions rather than just shaving off the bump. Founder John Treace started the Florida-based company in 2014 after years at another medical-device firm, naming it after himself. Its tools treat the unstable joint at the root of the bunion, not just the cosmetic lump, and surgeons have used them on well over a hundred thousand patients.
Granted 250.0K · Bought 399.8K
Granted 475.0K
Granted 262.5K
Granted 332.9K
Granted 30.0K
Granted 150.0K
Granted 30.0K
Granted 30.0K
Granted 30.0K
Granted 30.0K
Granted 30.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Treace John T.Chief Executive Officer, Director, 10% owner · 17 transactions | +5.1% | 12.73M | 250.0K | 399.8K | — |
| Hair MarkChief Financial Officer · 7 transactions | +83.4% | 952.0K | 475.0K | — | — |
| Elder Scot MichaelChief Legl & Comp Off, CorpSec · 8 transactions | +40.4% | 794.9K | 262.5K | — | — |
| Scanlan Sean F.Chief Innovation Officer · 6 transactions | +88.5% | 704.7K | 332.9K | — | — |
| Bakewell John KDirector · 1 transaction | +5.8% | 546.4K | 30.0K | — | — |
| Guglielmino GaetanoChief Commercial Officer · 1 transaction | — | 490.9K | 150.0K | — | — |
| Guglielmino GuyChief Commercial Officer · 2 transactions | — | 342.9K | — | — | — |
| Jain DeeptiDirector · 1 transaction | +42.7% | 100.2K | 30.0K | — | — |
| Kiernan Jane EDirector · 1 transaction | +46.9% | 93.9K | 30.0K | — | — |
| Hanna BetsyDirector · 1 transaction | +66.3% | 75.2K | 30.0K | — | — |
| Berry Lance ADirector · 1 transaction | +67.3% | 74.6K | 30.0K | — | — |
| Hamilton Lawrence WDirector · 1 transaction | +68.1% | 74.1K | 30.0K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: +399.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.